Rigel Pharmaceuticals, Inc.RIGLNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending higher, above historical average, strong compound growth.
Left:
||||
Price-to-book ratio
Latest
89.93
↑ 674% above average
Average (9y)
11.63
Historical baseline
Range
High:89.93
Low:-18.99
CAGR
+46.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 89.93 | +1120.9% |
| 2023 | -8.81 | +53.6% |
| 2022 | -18.99 | -227.7% |
| 2021 | 14.87 | -14.3% |
| 2020 | 17.36 | +161.0% |
| 2019 | 6.65 | +97.9% |
| 2018 | 3.36 | -31.0% |
| 2017 | 4.87 | +19.3% |
| 2016 | 4.08 | +39.2% |
| 2015 | 2.93 | - |